TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

Insider Trading Alert - EAT, NAVB And INTC Traded By Insiders

  • By TheStreet Wire
  • Nov 5, 2015 12:45 PM EST
PRESS RELEASES

Navidea Biopharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Virtual Conference

  • By Business Wire
  • Mar 2, 2021 4:01 PM EST
PRESS RELEASES

Navidea Biopharmaceuticals Announces $5 Million Private Placement With Existing Investor

  • By Business Wire
  • Mar 2, 2021 7:30 AM EST
PRESS RELEASES

Navidea Biopharmaceuticals Announces Submission Of Formal Type B Meeting Request With FDA And Launch Of NAV3-32 Phase 2B Trial In Rheumatoid Arthritis

  • By Business Wire
  • Feb 8, 2021 4:05 PM EST
PRESS RELEASES

Navidea Biopharmaceuticals To Present At The 2021 ICR Conference On January 14, 2021

  • By Business Wire
  • Jan 7, 2021 7:30 AM EST
PRESS RELEASES

Navidea Biopharmaceuticals Strengthens Board Of Directors With The Appointment Of Malcolm Witter

  • By Business Wire
  • Dec 28, 2020 7:30 AM EST
PRESS RELEASES

Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study In Rheumatoid Arthritis

  • By Business Wire
  • Nov 12, 2020 4:01 PM EST
PRESS RELEASES

Navidea Biopharmaceuticals To Host Third Quarter 2020 Earnings Conference Call And Corporate Update

  • By Business Wire
  • Nov 5, 2020 4:01 PM EST
PRESS RELEASES

Navidea Biopharmaceuticals To Present At The Virtual Investor KOL Roundtable

  • By Business Wire
  • Oct 22, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Announces Acceptance Of Abstract For Presentation At The American College Of Rheumatology Annual Meeting

  • By Business Wire
  • Oct 9, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Ring Opening Bell At The New York Stock Exchange

  • By Business Wire
  • Sep 28, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Present At H.C. Wainwright 22nd Annual Global Investment Conference

  • By Business Wire
  • Sep 8, 2020 4:05 PM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Wins Dismissal Of Platinum Loan Litigation

  • By Business Wire
  • Sep 2, 2020 4:05 PM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Present At The LD 500 Virtual Investor Conference

  • By Business Wire
  • Aug 24, 2020 4:05 PM EDT
PRESS RELEASES

Jubilant Radiopharma And Navidea Biopharmaceuticals Sign Binding Memorandum Of Understanding For Commercialization Partnership

  • By Business Wire
  • Aug 10, 2020 9:08 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Signs Binding Framework For Commercialization Partnership With Jubilant Radiopharma

  • By Business Wire
  • Aug 10, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Host Second Quarter 2020 Earnings Conference Call And Corporate Update

  • By Business Wire
  • Aug 6, 2020 4:15 PM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Announces Full Enrollment In Its Ongoing Phase 2B Trial Of Tc99m Tilmanocept In Rheumatoid Arthritis (RA)

  • By GlobeNewswire
  • Jun 15, 2020 8:00 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Present At The Virtual Investor Fireside Chat Series

  • By GlobeNewswire
  • Jun 9, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Announces Acceptance Of Abstract For Presentation At The European League Against Rheumatism (EULAR) Congress

  • By GlobeNewswire
  • Jun 3, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Regains Commercialization And Distributions Rights In Europe For LYMPHOSEEK®

  • By Business Wire
  • May 11, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals To Host First Quarter 2020 Earnings Conference Call And Corporate Update

  • By Business Wire
  • May 7, 2020 7:00 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Provides Statement Regarding COVID-19 Pandemic

  • By Business Wire
  • Apr 22, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Signs Letter Of Intent With WorldCare Clinical To Partner On Navidea's Rheumatoid Arthritis Clinical Imaging Workflow And Commercialization; Other Business Updates

  • By Business Wire
  • Mar 31, 2020 7:30 AM EDT
PRESS RELEASES

Navidea Biopharmaceuticals Announces Issuance Of Patent Extension For Lymphoseek®

  • By Business Wire
  • Mar 20, 2020 7:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.